EMEA-000311-PIP05-17-M02
Key facts
Invented name |
Stelara
|
Active substance |
Ustekinumab
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0281/2020
|
PIP number |
EMEA-000311-PIP05-17-M02
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of ulcerative colitis
|
Route(s) of administration |
|
Contact for public enquiries |
Janssen Cilag International NV
Tel. +3214602111 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|